Stereotactic body radiation therapy for inoperable early stage lung cancer. - Wikidata - wikimedia - TriplyDB

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

http://www.wikidata.org/entity/Q34010065

about

Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives Non-small cell lung cancer: current treatment and future advances Mouse models for radiation-induced cancers Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologist Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome Radioresistance of Brain Tumors Neoadjuvant radiotherapeutic strategies in pancreatic cancer Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery Clinical utility of RapidArc™ radiotherapy technology.Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization)A review of stereotactic body radiotherapy - is volumetric modulated arc therapy the answer?Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?Lung cancer ablation: technologies and techniques Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?Emerging Treatment Paradigms in Radiation Oncology Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer Advances of treatment about elderly clinical stage I non-small cell lung cancer Cancer concepts and principles: primer for the interventional oncologist-part II Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease Stereotactic body radiotherapy: current strategies and future development Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?Stereotactic radiotherapy for early lung cancer: Evidence-based approach and future directions Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials

P2860

Q26738434-86777985-C926-4031-A4F6-E34EC66A0ADE Q26740333-1676EC40-429D-43D8-B89C-43A092EDB58E Q26747129-79E43C70-320A-4525-814A-EAD7605D7330 Q26747145-8CC6391E-4486-4363-B076-94CF01F308CF Q26749415-531F4105-47A4-4E88-94EA-5CE570BB5C88 Q26752579-087F4505-076D-48F2-AB72-F04E5FEDE78B Q26766686-2A80A3E1-FE97-4B56-AECA-1BE7BB7E2C09 Q26766890-B62A7D0A-0DC5-47CF-A7F9-9785ED252FE8 Q26770254-6225B6FB-695F-4314-AA7C-F951CAA7F23C Q26772259-06C3DBA3-2E1B-48B9-B3F1-2F8DFBE6C36B Q26773193-5559540C-B19A-439D-8785-AAC19A1C9B70 Q26775388-A420AE71-097D-4CE3-ADC5-A16C4EF0C518 Q26796394-85EAFBEA-9068-4C4A-A82B-09E2CCCC0600 Q26796524-C2DEAF4C-F04A-4527-B11C-95936353E515 Q26801050-76F4F4BA-67D7-4FFE-AAB5-6AAA72013424 Q26823670-05573FE4-2572-456A-B72E-543EE8C2DB90 Q26827382-D42297B9-CE92-4904-90A4-431F3F0AAED9 Q26827571-83B15A94-03B0-4433-BCF1-59F82763AB21 Q26851601-F532971F-2745-4192-9141-52C0CA0AF9D4 Q26852685-290A23CA-9EE4-47C2-A051-4A5A2E5291B4 Q26853124-F43A319D-34CA-41BF-A2B2-88F585E11C01 Q26853461-339D20C6-8124-4FD8-9C2F-3A432A449937 Q26864983-38DADAC7-5629-49F8-9040-DF3D874BCAE0 Q26866335-BA18BF6B-B01B-4DA6-9C9E-BF3F0F8FA497 Q27008257-9D15BDCC-691C-4223-B343-A2CB5F653E1F Q27010961-07BEF7FA-1D2E-4AB3-8F2F-634F47E0FEE4 Q27015651-F9613A39-FB1C-45C2-9788-5408E33C8B21 Q27016589-63756DAF-2D0B-4E42-BC76-E3A19EDF2042 Q27023426-0BA5E553-5E8A-4EC6-BE35-8F9D21AF3677 Q27301421-398BFC1A-1825-4552-AD38-C05B2FA70D03 Q27307731-FA28C0F9-6475-4AA0-97B5-7177F8E17D8E Q27309908-A4516DDC-59D6-4D94-8E51-A079EDB873DB Q28071733-CA97D0C0-9AA5-425B-AD99-686949A04ADC Q28076058-989118BB-28BC-4A88-9AA7-0845D6A24BB6 Q28079996-EF475EBD-886B-419D-9F0D-7ED496C3DC02 Q28083924-57771820-168A-4200-93E4-1A2C7F430D8B Q28085744-92FF4B4C-BD64-4BB0-B81D-99BD175985E6 Q28086904-DBE0BDAC-A974-4025-A126-E1AECF67A1F9 Q28730322-98B355E8-57A7-4946-AEB8-682E74527E4F Q30278410-CA9A5CBA-8936-4A2C-9E34-A6B671685B73

P2860

Stereotactic body radiation therapy for inoperable early stage lung cancer.

http://www.wikidata.org/entity/Q34010065

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@ast

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@en

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@nl

type

label

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@ast

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@en

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@nl

prefLabel

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@ast

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@en

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@nl

P1433

Q34010065-984D4E78-0AC7-4308-BB7D-8880744E49CD

P1476

Q34010065-417E2627-8757-4089-BD26-1D163FB289A3

P2093

Q34010065-075516EC-A745-4FAD-AAA0-67C93BAFA459

Q34010065-1F07EF18-D49A-4520-98C9-8DEC92D89F96

Q34010065-30EE71D7-BB9F-4A27-B20C-82BFFE22675D

Q34010065-45CBF94C-4413-42B9-95A7-5999BF810F1B

Q34010065-51142D81-39B0-4F47-8ACC-E21F495263F6

Q34010065-5B390524-4839-4A55-9A4C-AA533EE8506A

Q34010065-7431AE9A-45EC-4A42-8CBB-0AD35F98C353

Q34010065-80C3E071-A7FE-4DCB-B775-741B6FDD523F

Q34010065-81B69747-1CA0-432C-9CFA-11778F706DB7

Q34010065-89EE654C-1B34-4456-85CD-8363B3C9E48E

P2860

Q34010065-2031B79E-24CC-46D3-ABDB-4CDB3D42C05E

Q34010065-2B4F5FED-F290-41EC-B9E3-78CF2E9CA9D6

Q34010065-408EE5FD-8EBC-42F5-BD04-8363CFB84BD8

Q34010065-444D40F3-C76C-439D-BF6D-0A81CBA441E1

Q34010065-6FE26A8A-67CA-4CF6-A420-A4E8EAF28C9C

Q34010065-7A941A82-941B-4810-81B6-E0B7B5BF65A0

Q34010065-7D9EEB22-CD3A-4DB1-8F1F-4808D837D0F0

Q34010065-7DE4B855-9E65-4A22-BB8F-AF83114A4320

Q34010065-854ECB98-112C-4F5A-AF5B-B1F3692FCE4D

Q34010065-85738174-AF8F-4038-ABED-EDF0228012F5

P304

Q34010065-88380E99-6C5C-4D36-826B-441015B3EED3

P31

Q34010065-480D14D2-693E-4968-A625-82ECEEAF66D1

P356

Q34010065-B8414F89-4B7E-4595-8424-60C33B97D572

P407

Q34010065-51C68890-933A-4968-B380-4CBA925793BB

P433

Q34010065-E21302BF-6B24-4D7D-815B-1AD67453EB19

P478

Q34010065-71ECCFA9-BC87-4D9A-92C8-B70C469B7EB4

P577

Q34010065-ED46945B-D979-40C1-A071-9A30F33E9D56

P5875

Q34010065-E7C847B3-F87B-4813-97A7-8043E2A182C5

P698

Q34010065-2DCC30C7-EE21-4608-85B3-2DC7F16269DC

P921

Q34010065-4D6EA85E-DC41-4510-AC6A-BB05323D83F4

P932

Q34010065-E158720D-F966-4F11-AF77-DB90A5AA009C

P356

P1433

Journal of the American Medical Association

P1476

Stereotactic body radiation therapy for inoperable early stage lung cancer.

@en

P2093

Achilles Fakiris

http://www.w3.org/2001/XMLSchema#string

Andrea Bezjak

http://www.w3.org/2001/XMLSchema#string

David Johnstone

http://www.w3.org/2001/XMLSchema#string

Elizabeth Gore

http://www.w3.org/2001/XMLSchema#string

Gregory Videtic

http://www.w3.org/2001/XMLSchema#string

Hak Choy

http://www.w3.org/2001/XMLSchema#string

Jack Fowler

http://www.w3.org/2001/XMLSchema#string

James Galvin

http://www.w3.org/2001/XMLSchema#string

Jeffrey Bradley

http://www.w3.org/2001/XMLSchema#string

Jeffrey Michalski

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy.

Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.

Stereotactic body radiation therapy in multiple organ sites.

Radiation therapy for medically inoperable stage I and II non-small cell lung cancer.

Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies.

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

P304

1070-1076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2010.261

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

303

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42108901

http://www.w3.org/2001/XMLSchema#string

P698

20233825

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2907644

http://www.w3.org/2001/XMLSchema#string